Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Clinical trial NCT03150693 · RECRUITING
Trial details
- NCT number
- NCT03150693
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2027-03-01
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.